Skip to main content

AMCP Nexus 2025 Posters Main banner

Genitourinary

Genitourinary

Type here to filter the list

(190) Budget impact analysis of generic mirabegron in Medicare Part D: translating savings into access
(191) Utilization of Medications for Overactive Bladder / Urinary Incontinence during 2018-2022: Analysis of the Medicare Part C and D Prescribers - by Provider and Drug Dataset
(192) Real-world characteristics of patients with overactive bladder initiating vibegron or mirabegron
(193) Proton pump Inhibitors are associated with an Increased risk of mortality among patients with kidney disease: A systematic review and meta-analysis